Search
Incyte Corp
INCYAdd to Watchlist
119.650USD
+1.640+1.39%
Close 11-05 16:00（ET）
24.39BMarket Cap
16.40P/E TTM
After-hours 16:12 (ET)119.550USD-0.240-0.20%
After-hours 16:12 (ET)Today
+1.39%
5 Days
+2.44%
1 Month
+4.84%
6 Months
+22.76%
Year to Date
+21.14%
1 Year
+13.20%
Key Figures
116.375Open
123.960High
246.35KVolume
16.40P/E TTM
13.48P/E Dynamic
--Dividend TTM
0.12%Turnover Ratio
118.010Prev. Close
115.805Low
29.22MTurnover
747.76P/E Static
4.32P/B
0.00%Div Yield TTM
21.88%ROA
132.60052wk High
45.75Volume Ratio
32.62MNet Profit
203.83MShares
7.2963EPS TTM
0.79Beta
30.82%ROE
89.25052wk Low
6.91%Amplitude
92.93%Gross Margin
24.39BMarket Cap
2.13Reward/Risk
2.09%Risk Rate
Incyte Corp's Score
-0.24vs previous score
Forecast7.31
Financial Health7.02
Technical3.52
Valuation Dimensions7.78
Institutional Confidence10.00
Risk Assessment8.57
Media Coverage
Coverage Level
Very Low
Very High
No data
Analyst Rating
Incyte Corp Technical Analysis
Technical Indicators
Sell
Summary
Buy
Moving Average
Strong buy
Incyte Corp Latest Earnings Call Transcripts
Incyte Q3 2026 Earnings Call: Revenue Up 14%, Sales Guidance Raised
Incyte Q3 2026 revenue rose 14% to $1.56 billion as Opzelura gained 36%. Management raised total net sales guidance to $5.2-$5.3 billion.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
-3.86/-3.85
Revenue / Forecast
1.56B/1.47B
Incyte Corp Profile
SectorPharmaceuticals
Ticker SymbolINCY
Number of employees2617
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Baker Bros. Advisors LP | 15.46% |
| Dodge & Cox | 6.64% |
| BlackRock Institutional Trust Company, N.A. | 5.99% |
| Vanguard Capital Management, LLC | 5.47% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 38.81% |
| Investment Advisor/Hedge Fund | 38.57% |
| Hedge Fund | 18.89% |
| Pension Fund | 4.47% |
Related Instruments
-0.79%
+1.43%
+1.07%
-0.14%
+0.38%
-0.22%
+0.03%
-0.41%
+0.02%
-0.20%
+0.85%
-1.57%
-1.04%
+0.28%
+5.27%
-0.16%
+0.16%
-0.80%
+1.46%
+3.63%Popular Instruments
51290.600
-208.500 (-0.41%)
26964.500
+329.300 (+1.24%)
7380.000
+23.100 (+0.31%)
12797.000
-1.000 (-0.01%)
58142.000
+876.000 (+1.53%)
6140.600
-37.200 (-0.60%)
89.857
-0.176 (-0.20%)
342.370
-1.800 (-0.52%)
186.640
+5.040 (+2.78%)
4065.670
-33.020 (-0.81%)
FAQs
What is the current price of Incyte Corp (INCY)?
The current price of Incyte Corp (INCY) is 118.01.
What is the symbol of Incyte Corp?
The ticker symbol of Incyte Corp is INCY.
What is the 52-week high of Incyte Corp?
The 52-week high of Incyte Corp is 132.60.
What is the 52-week low of Incyte Corp?
The 52-week low of Incyte Corp is 89.25.
What is the market capitalization of Incyte Corp?
The market capitalization of Incyte Corp is 24.05B.
Is Incyte Corp (INCY) currently rated as Buy, Hold, or Sell?
According to analysts, Incyte Corp (INCY) has an overall rating of Buy, with a price target of 131.38.
What is the Earnings Per Share (EPS TTM) of Incyte Corp (INCY)?
The Earnings Per Share (EPS TTM) of Incyte Corp (INCY) is 7.30.